Juan M. Madrigal-Blanco
Bilbao, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Window of opportunity with abatacept in Rheumatoid arthritis-associated interstitial lung disease: A multicentre study of 526 patients.
Journal: European journal of internal medicine
Published: April 01, 2026
Real-world experience of anifrolumab in 30 patients with refractory DM: a multicentre-multidisciplinary retrospective study.
Journal: Rheumatology (Oxford, England)
Published: August 27, 2025
Real-world experience of anifrolumab in 30 patients with refractory dermatomyositis: a multicenter-multidisciplinary retrospective study.
Journal: Rheumatology (Oxford, England)
Published: August 27, 2025
The role of NFKB1 and NFKBIA in immunoglobulin A vasculitis.
Journal: Frontiers in immunology
Published: August 26, 2025
Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicentre cohort of 526 patients.
Journal: Rheumatology (Oxford, England)
Published: August 26, 2025
Evaluating the usefulness of C5 and C5AR1 as genetic biomarkers of IgA-mediated vasculitis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: February 19, 2025
Baricitinib in rheumatoid arthritis-interstitial lung disease: a literature review and national multicentre study of 72 patients.
Journal: Rheumatology (Oxford, England)
Published: January 22, 2025
Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients.
Journal: Seminars in arthritis and rheumatism
Published: March 04, 2024
Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry.
Journal: Annals of the rheumatic diseases
Published: November 13, 2023
Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?
Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?
Journal: International journal of molecular sciences
Published: August 04, 2023
Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register.
Journal: Seminars in arthritis and rheumatism
Published: May 08, 2023
Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry.
Journal: Rheumatology and therapy
Published: September 05, 2022
Last Updated: 09/26/2026